EADV: Hidradenitis suppurativa carries high cardiovascular riskOctober 26, 2015DiabetesLipid Disorders
EASD: Evolocumab shows ‘promising efficacy’ in type 2 diabetesOctober 19, 2015DiabetesLipid Disorders
TCT: Everolimus stents best paclitaxel for diabetes patientsOctober 15, 2015CAD & AtherosclerosisInterventional Cardiology & SurgeryDiabetes
EASD: Studies slam cardiovascular safety of sulfonylureasOctober 13, 2015DiabetesAcute Coronary SyndromesLipid Disorders
EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetesOctober 1, 2015DiabetesLipid Disorders
Long-acting insulin degludec – and degludec combo drug – win FDA nodSeptember 26, 2015Lipid DisordersDiabetes
Empagliflozin’s triumph respins FDA’s diabetes drug mandateSeptember 21, 2015Heart FailureAcute Coronary SyndromesDiabetes
EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetesSeptember 18, 2015DiabetesAcute Coronary SyndromesLipid Disorders
No difference in long-term cost for diabetes treatment with bariatric surgerySeptember 17, 2015Diabetes
Long-acting basal insulin controls HbA1c as well as glargineSeptember 16, 2015DiabetesLipid Disorders
ESC: Further data indicate no excess heart failure risk with lixisenatide or sitagliptinSeptember 13, 2015DiabetesHeart Failure
